Document is current
Any future updates will be listed below
-
Authors
Toren, Yael
Ziv, Yarden
Sragovich, Shlomo
McKinney, R. Anne
Barak, Segev
Shazman, Shula
Gozes, Illana
-
Funding
Funding for this research was provided by:
Tel Aviv University
- License Information
-
More Information
Article History
Received: 25 May 2024
Accepted: 29 May 2024
First Online: 10 September 2024
Declarations
:
: I.G., VP Drug Development, Exonavis Therapeutics Ltd. Sex-dependent use of davunetide is patent pending, and I.G. is listed as an inventor. I.G. also serves as Editor-in-Chief of <i>Journal of Molecular Neuroscience</i>.
